Status:
COMPLETED
Evaluation of Respiratory Function in Fibromyalgia
Lead Sponsor:
Uppsala University
Conditions:
Fibromyalgia
Respiratory Alkalosis and Metabolic Acidosis
Eligibility:
All Genders
20-65 years
Brief Summary
This study will evaluate respiratory function in people with fibromyalgia and whether or not breathing patterns in this patient group can be explained by stress, emotional or biomechanical variables. ...
Detailed Description
Fibromyalgia is characterized by persistent widespread pain and affects approximately 1-3% of the general population. Fibromyalgia is a multifactorial syndrome and much research has been done and seve...
Eligibility Criteria
Inclusion
- Male or female with fibromyalgia according to American College of Rheumatology criteria 2010.
- Age 20 to 65 years
- Informed consent.
Exclusion
- Trauma in neck-shoulder or thoracic region with prolonged symptoms during the last three months before examination.
- Severe illness (neurological e.g Parkinson disease, neuromuscular e.g Multiple sclerosis, respiratory e.g chronic obstructive pulmonary disease, muscle/skeletal disease e.g ankylosing spondylitis)
- Inability to understand or follow instructions in Swedish
- Use of antidepressant drugs
- For the healthy controls, any other complaints from the chest wall and neck and shoulder region within three month before examination.
- N.B Smoking will not be an exclusion criterion.
Key Trial Info
Start Date :
June 28 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04098731
Start Date
June 28 2018
End Date
February 1 2022
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nyköping hospital
Nyköping, Sörmland, Sweden, 61185